Found 5 matching trials
Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder
PHASE2study objectives are to compare the efficacy, safety and tolerability of tw...
Location
Geha Medical Centre
Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects
PHASE1This clinical study is designed to evaluate the safety and tolerability of ...
Location
ADHD Unit, Geha MHC, Israel
Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD)
PHASE2The purpose of this study is to evaluate efficacy, safety and tolerability ...
Location
Cognitive Neurology unit Rambam Health Care Campus
Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects
PHASE2The purpose of this study is to evaluate the safety and tolerability of a s...
Location
Rambam Medical Center
A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
PHASE2This study is a multisite, randomized, double-blind, placebo-controlled, ph...
Location
Southwest Autism Research & Resource Center